Anthony Vecchione
The Alzheimer's Disease Data Initiative is accepting applications for a $1 million first prize for agentic AI Alzheimer's research.
The partnership aims to provide caregivers with career mobility and agencies with streamlined operations and consistent training standards.
The partnerships come in the wake of an eight-year legal battle in which IQVIA accused Veeva of stealing trade secrets.
CredAlliance aims to eliminate duplication of the credentialing process for providers.
ArteraAI Prostate uses digital pathology images from a patient’s biopsy to predict potential long-term outcomes of their prostate cancer.
ArteraAI Prostate forecasts potential long-term outcomes of a patient's prostate cancer biopsy slide based on digital pathology images.
The financing comes on top of the company's $900 million annual research and development investment in the U.S.
The company plans to launch the first version of its AI Advocate tool, aimed at helping patients manage and guide their overall healthcare, in the third quarter of this year.
The alliance aims to benefit patients with chronic conditions and allow real-time interoperability among healthcare providers, pharmacies and payers.
Data from Dexcom CGMs will be integrated into FriskaAi and will be monitored by AI-powered algorithms that alert patients when action is advised.